Delayed
TEL AVIV STOCK EXCHANGE
10:24:21 2024-05-06 am EDT
|
5-day change
|
1st Jan Change
|
41.9
ILa
|
-3.90%
|
|
-6.68%
|
-67.67%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
683.7
|
127.1
|
18.89
|
34.68
|
Enterprise Value (EV)
1 |
542.9
|
29.35
|
-38.08
|
11.31
|
P/E ratio
|
-8.66
x
|
-2.36
x
|
-0.42
x
|
-0.95
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
33,049,534
x
|
45,542,823
x
|
5,953,284
x
|
7,005,220
x
|
EV / Revenue
|
26,244,931
x
|
10,519,167
x
|
-12,002,594
x
|
2,284,412
x
|
EV / EBITDA
|
-20.4
x
|
-0.55
x
|
0.86
x
|
-0.32
x
|
EV / FCF
|
-37,376,154
x
|
-1,297,859
x
|
1,486,685
x
|
-532,779
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
-0%
|
Price to Book
|
4.59
x
|
1.22
x
|
0.31
x
|
1.31
x
|
Nbr of stocks (in thousands)
|
26,664
|
26,756
|
26,756
|
26,756
|
Reference price
2 |
25.64
|
4.749
|
0.7060
|
1.296
|
Announcement Date
|
3/18/21
|
3/24/22
|
3/23/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
12.19
|
20.69
|
2.79
|
3.173
|
4.95
|
EBITDA
1 |
-30.43
|
-47.92
|
-26.58
|
-52.99
|
-44.04
|
-35.87
|
EBIT
1 |
-30.83
|
-48.54
|
-27.21
|
-53.65
|
-44.65
|
-37.78
|
Operating Margin
|
-
|
-398.29%
|
-131.53%
|
-1,923.05%
|
-1,407.09%
|
-763.17%
|
Earnings before Tax (EBT)
1 |
-28.58
|
-49.15
|
-28.54
|
-53.62
|
-44.59
|
-36.64
|
Net income
1 |
-28.58
|
-49.15
|
-28.54
|
-53.62
|
-44.59
|
-36.64
|
Net margin
|
-
|
-403.36%
|
-137.98%
|
-1,921.97%
|
-1,405.36%
|
-740.1%
|
EPS
2 |
-18.10
|
-31.13
|
-2.959
|
-2.010
|
-1.670
|
-1.370
|
Free Cash Flow
|
-
|
-15.86
|
-14.53
|
-22.61
|
-25.62
|
-21.22
|
FCF margin
|
-
|
-130.15%
|
-70.22%
|
-810.5%
|
-807.34%
|
-428.77%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/16/20
|
11/16/20
|
3/18/21
|
3/24/22
|
3/23/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
11.3
|
19.1
|
141
|
97.7
|
57
|
23.4
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-15.9
|
-14.5
|
-22.6
|
-25.6
|
-21.2
|
ROE (net income / shareholders' equity)
|
-
|
-274%
|
-33.7%
|
-42.3%
|
-53.6%
|
-83.4%
|
ROA (Net income/ Total Assets)
|
-
|
-94.4%
|
-16.2%
|
-23.4%
|
-28.9%
|
-44%
|
Assets
1 |
-
|
52.09
|
176.4
|
229.4
|
154.1
|
83.29
|
Book Value Per Share
2 |
9.810
|
12.90
|
5.580
|
3.910
|
2.310
|
0.9900
|
Cash Flow per Share
2 |
7.130
|
14.70
|
5.520
|
2.200
|
1.110
|
0.4800
|
Capex
1 |
0.58
|
1.39
|
0.25
|
0.44
|
0.44
|
0.19
|
Capex / Sales
|
-
|
11.37%
|
1.18%
|
15.81%
|
13.87%
|
3.84%
|
Announcement Date
|
11/16/20
|
11/16/20
|
3/18/21
|
3/24/22
|
3/23/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -67.67% | 2.99M | | +73.17% | 12.38B | | -15.87% | 8.2B | | +17.74% | 7.3B | | +10.58% | 5.32B | | +33.33% | 4.78B | | -18.88% | 4.16B | | -35.55% | 2.43B | | +2.35% | 2.05B | | +9.66% | 1.98B |
Medical Equipment
|